Tonghua Dongbao Pharmaceutical announced that on November 4, 2024, the company received a notice from the controlling shareholder Dongbao Group regarding the special loan commitment letter for stock shareholding. Dongbao Group plans to increase its stake in the company through the Shanghai Stock Exchange trading system by centralized auction trading, with the shareholding ratio not less than 1% of the total share capital of the company, i.e., 19,817,341 shares, and not exceeding 2% of the total share capital of the company, i.e., 39,634,681 shares. Dongbao Group has obtained a "loan commitment letter" issued by Jilin Branch of Agricultural Bank of China Limited, granting a loan amount of 0.5 billion yuan with a term of 1 year, specifically for increasing the company's stocks through centralized auction trading method. The shareholding plan will be implemented within 12 months from October 31, 2024.